Clinical trial
Efficacy and Safety of Extended Release Niacin-Fenofibrate Combination and Monotherapy for the Treatment of Atherogenic Dyslipidemia in Obese Females
NCT03615534 is registered in ClinicalTrials.gov with Lewai Sharki Abdulaziz, MSc PhD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Extended Release Niacin-Fenofibrate Combination and Monotherapy for the Treatment of Atherogenic Dyslipidemia in Obese Females
- Lead sponsor
- Lewai Sharki Abdulaziz, MSc PhD
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- October 1, 2014
- Completion date
- October 30, 2015
- Enrollment
- 161 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
atherogenic dyslipidemia, obesity associated disorder